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        DCs orchestrate a repertoire of immune re-
sponses that ranges from tolerance to self-anti-
gens to resistance to infectious pathogens (  1, 2  ). 
In lymph nodes, immature DCs continually pre-
sent tissue antigens to self-reactive naive T cells, 
leading to abortive T cell proliferation and estab-
lishment of T cell tolerance (  3  –  5  ). In contrast, 
mature DCs present microbial antigens and typi-
cally induce robust eff  ector and memory T cell 
responses. In the latter case, DC maturation is ini-
tiated by microbial products, endogenous danger 
signals, or signals delivered by antigen-activated 
T cells, primarily through CD40L (  6  –  8  ). It is 
generally believed that full-blown T cell immune 
responses are dependent on a combination of 
stimuli derived from microbial products, endog-
enous danger signals, and feedback from T cells 
that act in a temporally and spatially ordered fash-
ion to induce DC maturation (  9, 10  ). However, 
it has been shown in some experimental systems 
that the triggering of CD40, by CD40L expressed 
on antigen-activated CD4  +   T cells or by agonistic 
antibodies, is suffi   cient to license DCs for priming 
of naive T cells against antigens administered in 
the absence of adjuvant (  11  –  14  ). 
  CD40L is a TNF family member that is 
rapidly up-regulated on antigen-activated T cells 
and released by activated platelets, and plays an 
important role in immune responses by regulat-
ing DC and B cell function (  15  ). Several studies 
have reported that CD4  +   eff  ector and memory 
T cells contain preformed CD40L in intracellu-
lar stores that can be rapidly mobilized to the 
cell surface after TCR stimulation (  16  –  18  ). Inter-
estingly, mouse naive CD4  +   T cells also consti-
tutively express low amounts of CD40L, which 
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  There is growing evidence that the maturation state of dendritic cells (DCs) is a critical 
parameter determining the balance between tolerance and immunity. We report that mouse 
CD4  +   effector memory T (T  EM  ) cells, but not naive or central memory T cells, constitutively 
expressed CD40L at levels suffi  cient to induce DC maturation in vitro and in vivo in the 
absence of antigenic stimulation. CD4  +   T  EM   cells were excluded from resting lymph nodes 
but migrated in a CD62P-dependent fashion into reactive lymph nodes that were induced 
to express CD62P, in a transient or sustained fashion, on high endothelial venules. Traffi  ck-
ing of CD4  +   T  EM   cells into chronic reactive lymph nodes maintained resident DCs in a mature 
state and promoted naive T cell responses and experimental autoimmune encephalomyelitis 
(EAE) to antigens administered in the absence of adjuvants. Antibodies to CD62P, which 
blocked CD4  +   T  EM   cell migration into reactive lymph nodes, inhibited DC maturation, T cell 
priming, and induction of EAE. These results show that T  EM   cells can behave as endogenous 
adjuvants and suggest a mechanistic link between lymphocyte traffi  c in lymph nodes and 
induction of autoimmunity. 
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CD40L (  Fig. 1 a  ).   In contrast, CD4  +   T  EM   cells homoge-
neously expressed low amounts of surface CD40L, which was 
signifi  cantly higher compared with naive T and T  CM   cells 
(  Fig. 1 a  ). Upon in vitro stimulation with CD3 antibodies, 
CD40L expression increased in all three subsets, although in 
T  EM   cells the kinetics were more rapid and the plateau level 
was     10-fold higher than that reached by naive T or T  CM   
cells (  Fig. 1 b  ). CD40L was also expressed on DO11.10 T  EM   
cells but not on DO11.10 naive or T  CM   cells (unpublished 
data). CD40L mRNA was found to be expressed in compara-
ble amounts in T  CM   and T  EM   cells (unpublished data), sug-
gesting that the diff  erence in protein expression may be caused 
by diff  erences in translation and/or storage. Consistent with 
this possibility, previous studies showed the presence of pre-
stored CD40L in memory T cells of both human and mouse 
origin (  16  –  19  ). 
  CD4  +   naive T, T  CM  , and T  EM   cells were then cultured 
with syngeneic immature BM-derived DCs, and the ex-
pression of DC activation markers was measured after 24 h. 
Although naive T and T  CM   cells did not induce DC matura-
tion, T  EM   cells induced up-regulation of CD40, CD86, and 
MHC class II molecules to an extent comparable to that in-
duced by LPS (  Fig. 1 c  ). DC maturation was also triggered by 
glutaraldehyde-fi  xed CD4  +   T  EM   cells (  Fig. 1 d  , top), indicating 
that the latter trigger DC maturation in the absence of anti-
gen-dependent or -independent signaling. In addition, CD4  +   
T  EM   cells did not induce maturation of CD40      /      DCs (  Fig. 1 d  , 
bottom), indicating that the maturation signal is delivered to 
DCs through a CD40  –  CD40L interaction. Collectively, these 
data indicate that mouse CD4  +   T  EM   cells, but not naive T or 
T  CM   cells, constitutively expressed CD40L at levels suffi   cient 
to trigger in vitro phenotypic maturation of DCs. 
  CD4  +   T  EM   cell  –  matured DCs prime naive T cells in vitro 
  We next asked whether T  EM   cell  –  matured DCs would be ca-
pable of priming naive T cells. Hemagglutinin (HA) peptide  –
  pulsed immature DCs were cultured with CFSE-labeled 
HA-specifi  c 6.5 TCR transgenic CD4  +   naive T cells alone or 
together with naive T, T  CM  , and T  EM   cells specifi  c for a diff  er-
ent antigen (DO11.10 TCR transgenic T cells recognizing 
OVA). HA-specifi  c naive T cells did not proliferate when 
stimulated with HA-pulsed immature DCs (  Fig. 2 a  ), consis-
tent with the notion that immature DCs have poor co-stimu-
latory capacity and fail to prime naive T cells (  26  ).   However, 
these cells proliferated vigorously and diff  erentiated to IFN-      –
  producing eff  ector T cells when stimulated with immature 
DCs in the presence of OVA-specifi  c T  EM   cells but not naive 
T or T  CM   cells (  Fig. 2 a   and not depicted). Similarly, CFSE-
labeled OVA-specifi  c CD4  +   naive T cells proliferated in re-
sponse to OVA-pulsed immature DCs when cultured with 
polyclonal CD4  +   T  EM   cells but not naive T or T  CM   cells (  Fig. 
2 b  ). Finally, in the presence of polyclonal CD4  +   T  EM   cells, 
OVA-specifi  c CD4  +   naive T cells proliferated in response to 
OVA peptide presented by wild-type but not CD40      /      DCs 
(  Fig. 2 c  ). The results of these in vitro experiments indicate 
that CD4  +   T  EM   cells can license immature DCs for priming of 
appears to be suffi   cient to induce survival of autoreactive B 
cells in the absence of T cell activation (  19  ). Whether circu-
lating naive or memory T cells may infl  uence the DC matu-
ration state in peripheral tissues or lymph nodes through 
constitutive expression of CD40L remains to be established. 
  Under steady-state conditions, migration of naive T cells 
and central memory T (T  CM  ) cells to peripheral lymph nodes 
is dependent on the expression of CD62L and CCR7, which 
mediate interaction with the cognate ligands peripheral node 
addressin (PNAd) and CCL21, respectively, expressed on high 
endothelial venules (HEVs) (  20  ). Eff  ector and eff  ector mem-
ory T (T  EM  ) cells, which lack CD62L and CCR7, are largely 
excluded from resting lymph nodes (  21  –  23  ). However, we 
recently demonstrated that CD8  +   T  EM   cells, as well as CCR7        
NK cells, can effi   ciently migrate into lymph node draining 
sites of injection of mature DCs or adjuvants (  24, 25  ). In reac-
tive lymph nodes, CD8  +   T  EM   and NK cells modulate ongoing 
responses by killing antigen-bearing DCs, thus limiting sec-
ondary immune responses, or by producing IFN-    , which 
enhances Th1 polarization. Recruitment of CD8  +   T  EM   and 
NK cells is dependent on the expression of CXCR3 on mi-
grating cells and coincides with a transient expression of its li-
gand, CXCL9, on HEVs of reactive lymph nodes (  24, 25  ). 
  In this paper, we report that mouse CD4  +   T  EM   cells, but 
not naive T or T  CM   cells, constitutively expressed CD40L at 
levels suffi   cient to trigger phenotypic maturation of DCs and 
license them for priming of naive CD4  +   T cells in vitro and 
in vivo. We also found that CD4  +   T  EM   cells were largely ex-
cluded from resting lymph nodes but migrated in a CD62P-
dependent fashion into reactive lymph nodes that were 
induced to express, in a transient (acute) or sustained (chronic) 
fashion, CD62P on HEVs. Strikingly, presentation of myelin 
oligodendrocyte glycoprotein (MOG) peptides by T  EM   cell  –
  licensed DCs in chronic reactive lymph nodes was suffi   cient 
to prime self-reactive T cells, leading to experimental auto-
immune encephalomyelitis (EAE). 
    RESULTS   
  CD4  +   T  EM   cells constitutively express CD40L 
and trigger DC maturation 
  It has been recently reported that naive CD4  +   T cells consti-
tutively express CD40L in amounts that are suffi   cient to pro-
mote autoreactive B cell survival (  19  ). We asked whether 
constitutive expression of CD40L on naive and memory T 
cell subsets would be suffi   cient to induce DC maturation. To 
generate memory T cells, BALB/c mice were either immu-
nized with KLH in CFA or were adoptively transferred with 
OVA-specifi  c DO11.10 TCR transgenic naive T cells and 
immunized with OVA-pulsed mature DCs. At least 4 wk 
after immunization, CD4  +   naive T cells (CD44  low  , CD62L  +  , 
CD127  +  ), T  CM   cells (CD44  high  , CD62L  +  , CD127  +  ), and T  EM   
cells (CD44  high  , CD62L       , CD127  +  ) were isolated from spleens 
of BALB/c mice (Fig. S1, available at http://www.jem.org/
cgi/content/full/jem.20081212/DC1) and stained with anti-
bodies to CD40L. Naive T and T  CM   cells isolated from KLH-
immunized mice did not express detectable levels of surface JEM VOL. 205, October 27, 2008 
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CXCL9, on HEVs of reactive lymph nodes (  24, 25  ). To in-
vestigate whether CD4  +   T  EM   cells would be also recruited 
to reactive lymph nodes, we injected i.v. in vivo  –  gener-
ated OVA-specific memory T cells, comprising both T  CM   
(CD127  +  CD62L  +  ) and T  EM   (CD127  +  CD62L       ) cells, into 
syngeneic mice and measured their migration into a reactive 
lymph node, which had been induced by s.c. injection of 
LPS-matured DCs, and into a resting lymph node as control 
(  Fig. 3 a  ).   As expected, T  CM   cells, which represented a mi-
nor fraction of the transferred cell population, were highly 
enriched in resting lymph nodes, accounting for up to 90% 
of the recruited cells. In contrast, T  EM   cells were virtually 
excluded from resting lymph nodes but effi   ciently migrated 
into reactive lymph nodes, where they accounted for up to 
naive T cells in an antigen-independent and CD40-dependent 
fashion, and raise the question of whether CD4  +   T  EM   cells 
might induce DC maturation in vivo. 
  CD4  +   T  EM   cells rapidly migrate into reactive lymph nodes 
in a CD62P-dependent, CXCR3-independent fashion 
  Mouse CD4  +   and CD8  +   T  EM   cells lack CCR7 and CD62L 
and are therefore largely excluded from lymph nodes in the 
steady state (  21  –  23  ). However, it is increasingly recognized 
that lymph nodes undergoing an immune response show an 
increased cellularity and become capable of recruiting CD8  +   
T  EM   and NK cells (  27  ). Recruitment of CD8  +   T  EM   and NK 
cells is dependent on expression of CXCR3 on migrating 
cells and coincides with a transient expression of its ligand, 
    Figure 1.         CD4  +   T  EM   cells constitutively express CD40L and promote DC maturation in vitro through CD40L  –  CD40 interaction.   (a) Surface 
expression of CD40L (black lines) in CD4  +   T naive (CD44  low CD62L + CD127 + ),  T CM   (CD44 high CD62L + CD127 +  ), and T  EM   (CD44 high CD62L     CD127 +  ) cells. Gray lines 
represent control staining with isotype-matched control antibodies. (b) Kinetics of CD40L surface expression on CD4  +   T cell subsets sorted as in panel a 
and stimulated in vitro with anti-CD3 and PdBU. Data are the means   ±   SD of three separate experiments. Student  ’  s   t   test on values at time 0: T  EM   versus 
T  CM  , P = 0.041; T  EM   versus T naive, P = 0.023; T  CM   versus T naive, NS. Unstimulated T cells cultured for the same time had a level of CD40L expression com-
parable to time 0 (not depicted). (c) Expression of CD40, CD86, and MHC class II (black lines) on DCs that had been cultured for 12 h with the indicated 
CD4  +   T cell subsets or stimulated with LPS. Gray lines represent staining of untreated immature DCs. Results are representative of four independent ex-
periments. (d) Expression of CD86 (black lines) in wild-type DCs (top) or CD40     /     DCs (bottom) cultured for 12 h with live or fi  xed CD4  +   T EM   cells or with 
LPS as control. Gray lines represent staining of untreated immature DCs. Results are representative of three independent experiments.   2564 DENDRITIC CELL LICENSING BY CD4  +   EFFECTOR MEMORY T CELLS   | Mart  í  n-Fontecha et al. 
cells generated in vivo by immunization of wild-type mice 
and transferred into mice lacking CD62P and CD62E selec-
tins failed to migrate to reactive lymph nodes (  Fig. 3 e  ). 
Furthermore, migration of T  EM   cells to reactive lymph nodes 
of wild-type mice was inhibited by injection of antibodies 
blocking CD62P but not CD62E (  Fig. 3 f  ). Collectively, 
these results indicate that recruitment of CD4  +   T  EM   cells into 
reactive lymph nodes is dependent on CD62P expression on 
endothelial cells but independent of CXCR3 expression on 
migrating T cells. 
  Transient and sustained expression of CD62P on HEVs 
of reactive lymph nodes 
  We next investigated whether and under which conditions 
CD62P would be expressed on HEVs of lymph nodes. Reac-
tive lymph nodes were induced by s.c. injection of either 
LPS-matured DCs or adjuvants. After 2 or 30 d, mice were 
injected i.v. with fl  uorescinated antibodies to CD62P to stain 
the luminal side of HEVs. Reactive and resting lymph nodes 
were collected and examined by immunohistology after coun-
terstaining with PNAd antibodies to identify HEVs. As shown 
in   Fig. 4 a  , CD62P was not expressed on the HEVs of resting 
lymph nodes.   After a single injection of mature DCs (DC 1  ×  ), 
CD62P was readily detected on day 2, persisted for     6 d, and 
was no longer detectable on day 30 (  Fig. 4 a   and not de-
picted). CD62P was also detected on HEVs of draining lymph 
nodes 2 d after injection of adjuvants such as CFA, CpG, LPS, 
IFA (  Fig. 4 b  ), R848, and TNF (not depicted). Remarkably, 
however, two consecutive injections 2 d apart of DCs (DC 
2  ×  ) or a single injection of CFA, but not one or two injec-
tions of CpG or LPS, led to a sustained expression of CD62P 
on HEVs for   >  30 d (  Fig. 4 a   and not depicted). The diff  erent 
staining patterns of CD62P and PNAd on HEVs may be 
caused by diff  erences in cellular localization or by technical 
reasons, because antibodies to CD62P were injected i.v., 
whereas anti-PNAd antibodies were added on tissue sections. 
  The sustained expression of CD62P on HEVs of lymph 
nodes stimulated by two injections of mature DCs or a sin-
gle injection of CFA correlated with a signifi  cant increase of 
lymph node cellularity that was sustained for up to 60 d af-
ter initial stimulation (  Fig. 4 c   and not depicted). In spite of 
the marked increase in total cell number, the relative propor-
tion of diff  erent cell subsets  —  including CD8  +   T, NK, NKT, 
and B cells, as well as plasmacytoid DCs, dermal DCs, and 
Langerhans cells  —  was comparable in resting and DC-reactive 
lymph nodes, with the only exception being CD4  +   T  EM   cells, 
which were highly enriched in reactive lymph nodes (  Fig. 
4 d  ). Lymph nodes stimulated 30 d earlier with two injec-
tions of DCs or one injection of CFA contained signifi  cantly 
higher numbers of endogenous CD4  +   CD44  high  CD127  +   
CD62L        T  EM   cells compared with resting lymph nodes, or 
lymph nodes stimulated by one injection of DCs or one or 
two injections of CpG or LPS (  Fig. 4 e  ). In addition, reactive 
lymph nodes induced 6 or 30 d before by one or two con-
secutive injections of LPS-matured DCs recruited i.v.-injected 
OVA-specifi  c T  EM   cells, indicating that T  EM   cell migration 
85% of the migrated cells, a fi  gure similar to that found in 
the spleen and infl  amed peritoneum (  Fig. 3 a  ). Transferred 
T  EM   cells were detected in reactive lymph nodes as early as 
20 min after i.v. injection (  Fig. 3 b  ), consistent with a direct 
migration of circulating T cells through HEVs rather than 
transit from tissues. In addition, 16 h after transfer, T  EM   cells 
colocalized with naive T cells in the T cell areas of reactive 
lymph nodes (Fig. S2, available at http://www.jem.org/cgi/
content/full/jem.20081212/DC1). 
  In vivo  –  generated CD4  +   T  EM   cells homogeneously ex-
pressed CXCR3, the receptor for CXCL9, a chemokine ex-
pressed on HEVs of reactive lymph nodes, and P-selectin 
glycoprotein ligand 1, the ligand for CD62P/CD62E ex-
pressed on endothelial cells and platelets (  Fig. 3 c  ) (  28  ). To 
investigate the requirements for CXCR3 in the process of 
CD4  +   T  EM   cell migration to reactive lymph nodes, T  EM  -like 
cells (96% CD62L negative) were generated in vitro from 
wild-type and CXCR3-defi  cient mice, mixed at a 1:1 ratio, 
and injected i.v. into mice carrying a reactive lymph node 
induced by s.c. injection of LPS-matured DCs. Surprisingly, 
wild-type and CXCR3-defi  cient T cells were recovered in 
similar proportions in spleens and reactive lymph nodes (  Fig. 
3 d  ), indicating that CXCR3 is not required for migration of 
CD4  +   T  EM   cells into reactive lymph nodes. In contrast, T  EM   
    Figure 2.         CD40L  +   CD4  +   T  EM   cells license DCs for T cell priming 
in vitro.   (a) Proliferation of CFSE-labeled HA-specifi  c 6.5 transgenic 
naive CD4  +   T cells cultured with 50   μ  M HA  110-119  – pulsed  syngeneic  imma-
ture DCs in the absence or presence of ex vivo  –  isolated OVA-specific 
DO11.10 transgenic CD4  +   T naive, T  CM  , or T  EM   cells. (b) Proliferation of 
CFSE-labeled OVA-specifi  c OT-II transgenic naive CD4  +   T cells cultured 
with 0.1   μ  M OVA  323-339    –  pulsed syngeneic immature DCs in the absence 
or presence of ex vivo  –  isolated polyclonal T naive, T  CM  , or T  EM   cells. 
(c) Proliferation of CFSE-labeled OVA-specifi  c OT-II transgenic naive CD4  +  
T cells cultured with polyclonal T  EM   cells in the presence of OVA-pulsed 
wild-type or CD40     /     immature DCs. Shown is the CFSE profi  le of T cells 
measured on day 5. Results are representative of at least three indepen-
dent experiments.     JEM VOL. 205, October 27, 2008 
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tion, the number of T  EM   cells in reactive lymph nodes de-
creased substantially (Fig. S3 b), indicating that T  EM   cells 
continually recirculate from blood to lymph node and from 
there to efferent lymph. We conclude that expression of 
CD62P on the luminal side of HEVs of reactive lymph nodes 
can be induced in a transient or sustained fashion depending on 
the nature of the eliciting stimulus, and coincides with in-
creased lymph node cellularity, which was caused by a uniform 
increase of all major cell subsets and a much higher increase of 
CD4  +   T  EM   cells. 
into reactive lymph nodes is not dependent on the presence of 
a specifi  c antigen (Fig. S3 a, available at http://www.jem.org/
cgi/content/full/jem.20081212/DC1). 
  The increased number of T  EM   cells found in reactive lymph 
nodes 30 d after injection of DCs or CFA may result from an 
increase in resident T  EM   cells or may depend on a continuous 
recruitment of T  EM   cells from the blood. To distinguish be-
tween these possibilities, we injected antibodies to CD62P, 
which, as shown in   Fig. 3 f  , block T  EM   cell recruitment into 
reactive lymph nodes. Within a few hours after antibody injec-
    Figure 3.         CD4  +   T  EM   cells rapidly migrate to reactive lymph nodes in a CD62P-dependent, CXCR3-independent manner.   Adoptively  transferred 
TCR transgenic OVA-specifi  c naive T cells were primed by immunization with an s.c. injection of 10  6   OVA-pulsed syngeneic LPS-matured DCs. 3 wk later, 
memory CD4  +   T cells were enriched from spleens and lymph nodes, and 3   ×   10  6   T cells were injected i.v. into mice in which reactive lymph nodes had been 
induced 24 h before by injection of 10  6   syngeneic LPS-matured DCs. Some mice received also an i.p. injection of thioglycolate 48 h before T cell transfer. 
(a) Relative proportion of DO11.10 CD4  +   T CM   (CFSE     KJ1-26 + CD62L + CD127 +  ) and T  EM   (CFSE     KJ1-26 + CD62L     CD127 +  ) cells in the population before transfer 
and in the indicated organs 12 h after transfer (percentages are shown). (b) Absolute number of DO11.10 CD4  +   T EM   (KJ1-26 + CD62L     CD127 +  ) cells in reac-
tive lymph nodes of mice 20 or 60 min after T cell transfer. (c) Expression of CD62P ligands and CXCR3 (black lines) on gated CD4  + CD62L       T EM   cells.  The 
gray dashed lines represent background staining. (d) Percentages of T  EM  -like cells from wild-type and CXCR3     /     mice in reactive lymph nodes and spleen 
24 h after i.v. injection. T cells were mixed at a ratio of 1:1, and 10  7   cells were injected in each mouse in which a reactive lymph node was produced by s.c. 
injection of 3   ×   10  6   mature DCs in the footpad. (e) Absolute number of OT-II CD4  +   T EM   (Ly5.1 + CD62L     CD127 +  ) cells in reactive lymph nodes of wild-type 
C57BL/6 or CD62P/E double-defi  cient mice. (f) Absolute number of DO11.10 CD4  +   T EM   (KJ1-26 + CD62L     CD127 +  ) cells in reactive lymph nodes of mice 12 h 
after injection of blocking antibodies to CD62P or CD62E or of isotype-matched control antibodies. Data are the means   ±   SD of two or three independent 
experiments each performed with two mice per condition. p-values were obtained with the Student  ’  s   t   test.   2566 DENDRITIC CELL LICENSING BY CD4  +   EFFECTOR MEMORY T CELLS   | Mart  í  n-Fontecha et al. 
cgi/content/full/jem.20081212/DC1), suggesting that T cells 
may be required for the establishment and/or maintenance of 
chronic reactive lymph nodes. When wild-type mice were in-
jected with antibodies to CD62P that prevent migration of 
T  EM   cells into reactive lymph nodes (  Fig. 3 f  ), the increase in 
  We also investigated the role of T cells in induction and 
maintenance of reactive lymph nodes. When CFA was in-
jected s.c. in CD3          /      mice, cell numbers in draining lymph 
nodes increased on day 2, but this increase was not sustained at 
later time points (Fig. S4 a, available at http://www.jem.org/
    Figure 4.         Expression of CD62P on HEVs of reactive lymph nodes correlates with increased lymph node cellularity and selective increase of 
T  EM   cell recruitment.   (a) Reactive lymph nodes were induced by one or two consecutive (2 d apart) injections of 10  6   LPS-matured DCs (DC 1  ×   and DC 
2  ×  , respectively). After 2 or 30 d, mice received an i.v. injection of 100   μ  g FITC-labeled anti-CD62P antibody. After 30 min, lymph nodes were collected, 
snap frozen, and processed for immunohistochemistry. Shown is the expression of PNAd (red) and CD62P (green) in resting and reactive lymph nodes. 
Bar, 100   μ  m. (b) CD62P expression in reactive lymph nodes detected by in vivo staining 2 d after s.c. injection of the indicated adjuvants. Results are rep-
resentative of three independent experiments. Bar, 100   μ  m. (c) Absolute cell number in resting and reactive draining lymph nodes at different time points 
after s.c. injection of PBS, as control or CFA, or one or two consecutive s.c. injections of mature DCs. The asterisk indicates the Student  ’  s   t   test on values: 
CFA versus PBS, P = 0.013; DC 2  ×   vs. PBS, P = 0.001. (d) Fold increase of the indicated cell populations in day 30 reactive lymph nodes compared with 
resting lymph nodes (naive, CD44  lo  ; memory, CD44  hi ;  T CM ,  CD44 hi CD62L + ;  T EM ,  CD44 hi CD62L      ; NK, CD3        NK1.1 +  ; NKT, CD3  +   NK1.1 +  ; B, CD3        CD19 + ;  pDC, 
B220  +   CD11c lo  ; dermal DC, B220        CD11c lo  ; LC, B220        CD11c hi  ). (e) Absolute number of endogenous T  EM   cells recovered in resting and reactive lymph nodes 
30 d after injection of DCs or adjuvants, as indicated. Data are the means   ±   SD of two to three separate experiments, each performed with two or three 
mice per condition. p-values were obtained with the Student  ’  s   t   test.   JEM VOL. 205, October 27, 2008 
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  In another experimental set up, we measured the prolifer-
ative response of naive T cells in the presence of adoptively 
transferred T  EM   cells (  Fig. 5 g  ). Mice transferred with CFSE-
labeled HA-specifi  c 6.5 naive T cells received a s.c. injection 
of LPS to induce a reactive lymph node. On day 5 after LPS 
injection, some mice were also transferred with OVA-specifi  c 
T  EM   cells, which had been either untreated or treated with 
anti-CD40L antibodies and then challenged i.v. with HA in 
PBS. HA-specifi  c T cells failed to proliferate in LPS-treated 
mice, consistent with our preliminary observation that the ad-
juvant eff  ect of LPS is rapidly lost in vivo (unpublished data). 
In contrast, HA-specifi  c T cells proliferated in lymph nodes 
containing T  EM   cells but not CD40L antibody  –  treated T  EM   
cells (  Fig. 5 h  ). Of note, treatment of CD4  +   T  EM   cells with 
anti-CD40L antibodies did not prevent their migration into 
reactive lymph nodes (unpublished data). Collectively, these 
results indicate that CD4  +   T  EM   cells migrating into chronic 
reactive lymph nodes act as an antigen-nonspecifi  c endog-
enous adjuvant by continuously triggering DC maturation in a 
CD40L-dependent fashion and facilitating T cell immune 
responses to otherwise nonimmunogenic antigens. 
  Induction of EAE in reactive lymph nodes in the absence 
of adjuvants 
  The fi  ndings described in the previous section raise the possi-
bility that in chronic reactive lymph nodes, CD4  +   T  EM   cells 
may license DCs for priming of autoreactive T cells. To test 
this possibility, we induced reactive lymph nodes by two 
consecutive injections of mature DCs or a single injection of 
CFA, and 1 mo later challenged the mice by s.c. injection of 
MOG peptides in PBS at sites draining into the reactive 
lymph node. Control mice were injected with MOG peptide 
in PBS or CFA. The clinical score of EAE was recorded in a 
blinded fashion by two researchers. In addition, brains and 
spinal cords were collected at the end of the experiments and 
analyzed for the presence of infi  ltrating CD4  +   T cells. 
  Injection of MOG peptide in CFA led to rapid develop-
ment of clinical symptoms of EAE and to accumulation of 
CD4  +   T cells in the central nervous system, whereas injec-
tion of MOG peptide in PBS did not result in any clinical 
symptoms or T cell infi  ltrate (  Fig. 6, a and b  ).   Remarkably, 
injection of MOG peptide in PBS in mice carrying a reactive 
lymph node, which had been induced by injection of either 
CFA or mature DCs 1 mo earlier, led to the development of 
clinical symptoms and T cell infi  ltrates that were comparable 
in severity and extent to those induced by the administration 
of MOG in CFA (  Fig. 6, c and d  ). Pretreatment of mice with 
anti-CD62P antibodies did not interfere with EAE induced 
by immunization with MOG peptide in CFA (  Fig. 6 a  ), con-
sistent with the fact that CD62P is not required for migration 
of eff  ector T cells into the brain (  29  ). Remarkably, however, 
anti-CD62P treatment prevented EAE and T cell infi  ltration 
in the central nervous system induced by injection of MOG 
peptide in PBS draining into reactive lymph nodes (  Fig. 6, 
c and d  ). Collectively, these data are consistent with a model 
in which CD4  +   T  EM   cells recruited into reactive lymph nodes 
lymph node cellularity was almost entirely prevented (Fig. S4 b), 
consistent with the possibility that T  EM   cells migrating in a 
CD62P-dependent fashion are required for long-term mainte-
nance of chronic reactive lymph nodes. 
  CD4  +   T  EM   cells in lymph node license DCs for T cell priming 
  The fi  nding that under certain conditions recruitment of T  EM   
cells in lymph nodes can be sustained for several weeks sug-
gests the possibility that these cells might infl  uence the DC 
maturation state through the constitutive expression of CD40L. 
To test this possibility, mice were transferred with Thy1.1  +   
OVA-specifi  c DO11.10 naive T cells and primed with one 
or two consecutive s.c. injections of OVA-pulsed DCs (OVA-
DC 1  ×   and OVA-DC 2  ×  , respectively) to generate T  EM   cells 
and to induce an acute or a chronic reactive lymph node 
(  Fig. 5 a  ).   Some mice were injected weekly with anti-CD62P 
blocking antibodies or isotype-matched control antibodies 
to inhibit T  EM   cell migration and the induction of chronic 
reactive lymph nodes. 30 d after priming, high numbers of 
DO11.10 T  EM   cells were recovered from chronic reactive but 
not acute reactive lymph nodes (Fig. S5, available at http://
www.jem.org/cgi/content/full/jem.20081212/DC1). Inter-
estingly, on day 30 after priming all DCs recovered from 
chronic reactive lymph nodes expressed increased levels of 
CD40 and MHC class II molecules as compared with DCs re-
covered from resting or acute reactive lymph nodes (  Fig. 5 b  ). 
At this late time point, there was no evidence of persisting 
OVA antigen in reactive lymph nodes, as shown by the lack 
of proliferation of i.v.-injected CFSE-labeled OT-II T cells 
(unpublished data). Strikingly, in mice treated with blocking 
CD62P antibodies, DCs did not show increased expression of 
CD40 and MHC class II molecules (  Fig. 5 b  ). These results 
are consistent with a role for lymph node  –  migrating CD4  +   
T  EM   cells in the induction of DC maturation in vivo. 
  We next asked whether T  EM   cell  –  matured DCs in chronic 
reactive lymph node would be capable of priming naive T 
cells to an antigen administered in the absence of adjuvant. 
Mice treated as above were adoptively transferred on day 30 
with CFSE-labeled HA-specifi  c 6.5 naive T cells and chal-
lenged by i.v. injection of HA in PBS (  Fig. 5 c  ). As expected, 
no proliferative response was observed in control mice in re-
sponse to HA administered in the absence of adjuvants. In ad-
dition, HA-specifi  c T cells did not proliferate in mice in which 
a transient reactive lymph node was induced by a single injec-
tion of DCs (1  ×  ). In contrast, a strong proliferative response 
of HA-specifi  c T cells was observed in chronic reactive lymph 
nodes induced by two injections of DCs (2  ×  ) and containing 
OVA-specifi  c T  EM   cells. Strikingly, HA-specifi  c T cells did 
not proliferate in mice chronically treated with CD62P anti-
bodies, which blocked T  EM   cell migration into lymph nodes 
and DC maturation (  Fig. 5 c   and Fig. S5). Comparable results 
were obtained in mice in which a reactive lymph node was 
induced by injection of CFA and that did not receive DO11.10 
T cell transfer (  Fig. 5, d  –  f  ), suggesting that CFA-induced T  EM   
cells emerging from the endogenous repertoire are suffi   cient 
to induce DC maturation and T cell priming. 2568 DENDRITIC CELL LICENSING BY CD4  +   EFFECTOR MEMORY T CELLS   | Mart  í  n-Fontecha et al. 
    Figure 5.         T  EM   cells migrating into reactive lymph nodes maintain DCs in a mature immunostimulatory state.   (a, d, and g) Experimental design. (a) Mice 
were transferred with Thy1.1  +   DO11.10  OVA-specifi  c T cells and either left untreated or primed with one or two s.c. injections of OVA-pulsed DCs to generate T  EM   
cells and acute or chronic reactive lymph nodes. Some mice were injected weekly with 100   μ  g of control antibodies or anti-CD62P blocking antibodies. (b) Ex-
pression of CD40 and MHC class II on CD11c  +   DCs  purifi  ed 30 d after priming from resting (gray lines) or reactive (black lines) lymph nodes. (c) On day 30, mice 
were transferred with CFSE-labeled HA-specifi  c 6.5 naive T cells and challenged with an i.v. injection of 10   μ  g HA in PBS. Shown are the percentages and the 
CFSE profi  les of 6.5  +   T cells in resting or reactive lymph nodes 5 d after challenge. (d) Mice received an s.c. injection of CFA to generate chronic reactive lymph 
nodes. Control mice received an s.c. injection of PBS. (e) Expression of CD40 and MHC class II on CD11c  +   DCs  purifi  ed 30 d after priming from resting or chronic 
reactive lymph nodes. (f) On day 30, mice were transferred with CFSE-labeled 6.5 naive T cells and challenged with an i.v. injection of 10   μ  g of HA protein in PBS. 
Shown are the percentages and the CFSE profi  les of 6.5  +   T cells in resting or chronic reactive lymph nodes 5 d after challenge. (g) Naive mice were adoptively 
transferred with CFSE-labeled 6.5 naive T cells, and a reactive lymph node was induced by s.c. injection of LPS. 5 d later, mice received an s.c. injection of HA in 
PBS together with an i.v. transfer of DO11.10 T  EM   cells that had been treated with control or CD40L-blocking antibodies. (h) Proliferative response of 6.5  +   T cells in 
reactive lymph nodes in the absence or presence of untreated or anti-CD40L  –  treated T  EM   cells. Results are representative of two to fi  ve separate experiments.    JEM VOL. 205, October 27, 2008 
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suggested to allow for CD62P-dependent homing of CD62L-
defi  cient leukocytes (  31  ). 
  CD62P expression is known to be induced on the endo-
thelial cells of infl  amed peripheral tissues and to regulate re-
cruitment of eff  ector cells of the innate and adaptive immune 
system (  32  ). Previous studies have shown that under condi-
tions of intravital microscopy (but not in situ), CD62P can be 
expressed on HEVs of Peyer  ’  s patches and subiliac lymph 
nodes and can account for residual migration of leukocytes in 
the absence of CD62L or     7-integrins (  33, 34  ). CD62P was 
also reported to be expressed at low levels on HEVs in the 
course of experimental mouse listeriosis (  35  ). Our results show 
for the fi  rst time that CD62P is induced in peripheral lymph 
node HEVs by s.c. injection of adjuvants or mature DCs and 
that it can mediate migration of CD4  +   T  EM   cells. Intriguingly, 
CD62P expression on HEVs can be acute or chronic, depend-
ing on the nature of the eliciting stimuli. Although soluble 
TLR agonists (LPS, CpG, and R848) or a single injection of 
mature DCs induced a transient expression of CD62P (up to 
day 6), a single injection of CFA or two consecutive injections, 
2 d apart, of mature DCs led to an up-regulation of CD62P 
that was sustained for   >  60 d. Importantly, the persistence of 
CD62P on HEVs correlates with increased lymph node cellu-
larity, recruitment of T  EM   cells, and increased immunostimula-
tory capacity of lymph node  –  resident DCs. Although the eff  ect 
of CFA may be explained by a sustained release of microbial 
products from a tissue depot, it remains to be established how 
two injections of mature DCs, which are known to be short 
lived, may induce a long-lasting change in the draining lymph 
node in the apparent absence of residual antigen, as shown by 
the fi   nding that 30 d after injection of OVA-pulsed DCs, 
CFSE-labeled OVA-specifi  c T cells failed to proliferate (un-
published data). 
  We have provided evidence that T cells may be required 
for maintenance of chronic reactive lymph nodes. Indeed, al-
though the initial increase of cell number in lymph nodes 
stimulated by adjuvants or mature DCs can be induced in T 
cell  –  defi  cient CD3          /      mice, the sustained increase in lymph 
node cellularity is dependent on the presence of T cells. The 
fi  ndings that antibodies to CD62P prevented migration of 
T  EM   cells and increased lymph node cellularity would be con-
sistent with a role for these cells in the development of chronic 
reactive lymph nodes. However, at this point we cannot rule 
out the possibility that cells other than T  EM   cells requiring 
CD62P to enter lymph node might also be involved. In addi-
tion, it is possible that other changes besides sustained ex-
pression of CD62P may take place in reactive lymph nodes. 
For instance, innate stimuli have been shown to promote re-
modeling of the primary feed arteriole, leading to an increase 
in lymphocyte input (  36  ). It is tempting to speculate that, 
once the inducing stimulus has reached a suffi   cient threshold, 
the reactive state of the lymph node may be maintained by ir-
reversible structural changes or by continuous recruitment of 
T  EM   and/or innate immune cells. 
  Another major fi  nding of this study is that CD4  +   T  EM   cells 
constitutively express CD40L at levels suffi   cient to trigger DC 
provide a licensing signal to resident DCs that facilitates re-
sponse to self-antigens and the development of pathogenic 
autoreactive T cells. 
    DISCUSSION   
  We have shown that CD4  +   T  EM   cells, which migrate with 
low effi   ciency into resting lymph nodes, migrate in a CD62P-
dependent fashion into reactive lymph nodes that have been 
induced to express, in a transient or sustained manner, CD62P 
on HEVs. In reactive lymph nodes, CD4  +   T  EM   cells trigger 
maturation of DCs in an antigen-independent fashion via 
constitutively expressed CD40L and license them for T cell 
priming against antigens, including self-antigens, administered 
in the absence of exogenous adjuvants. 
  We previously reported that, after s.c. injection of adju-
vants or mature DCs, draining lymph nodes become capable 
of attracting leukocytes, such as CD8  +   T  EM   and NK cells, that 
are largely excluded from resting lymph nodes (  24, 25  ). Entry 
of CD8  +   T  EM   and NK cells requires expression of CXCR3 
on migrating cells and coincides with expression of the cog-
nate chemokines on HEVs of reactive lymph nodes. Al-
though the ligand for CD62P is expressed on CD8  +   eff  ector 
T cells, this adhesion molecule is not required for homing of 
CD8  +   T cells to reactive lymph nodes, as demonstrated by 
experiments using specifi  c blocking antibodies (unpublished 
data). The present study shows that migration of CD4  +   T  EM   
cells into reactive lymph nodes occurs through a diff  erent 
mechanism independent of CXCR3 and dependent on 
CD62P. This conclusion is based on the fi  ndings that wild-
type and CXCR3-defi  cient CD4  +   T  EM   cells showed a com-
parable capacity to migrate into reactive lymph nodes, and 
that CD4  +   T  EM   cell migration was not observed in mice lack-
ing CD62P/E and could be inhibited by antibodies against 
CD62P but not CD62E. In addition, migration of CD4  +   
T  EM   cells in lymph nodes coincides with expression of CD62P 
on HEVs that was induced, in an acute or chronic fashion, 
by adjuvants or mature DCs. Interestingly, chronic reactive 
lymph nodes did not appear to effi   ciently recruit cytotoxic 
CD8  +   T  EM   cells as acute lymph nodes do (  25  ), indicating that 
entry of these cells is restricted to the early phases of an im-
mune response. 
  A recent study demonstrated that antigen-primed lymph 
nodes contain a resident population of antigen-specific 
CXCR5  +  ICOS  +   follicular helper T cells (  30  ). In contrast to 
follicular helper T cells, the CD4  +   T  EM   cells described in this 
paper continually recirculate through the reactive lymph nodes 
because they disappeared rapidly when entry was blocked by 
injection of CD62P antibodies. It remains to be established 
which lymphocyte integrin is involved in this process and 
whether chemokine-dependent activation of integrins is re-
quired, because the high amounts of LFA-1 and     4-integrins 
expressed on memory T cells may promote effi   cient adhesion 
of rolling cells even in the absence of chemokine signaling. In 
addition, one should consider the possibility that CD62P-ex-
pressing platelets adhering to HEVs may facilitate extravasation 
of P-selectin glycoprotein ligand 1  +   T  EM   cells, as it has been 2570 DENDRITIC CELL LICENSING BY CD4  +   EFFECTOR MEMORY T CELLS   | Mart  í  n-Fontecha et al. 
CD62P antibodies, which blocked T  EM   cell migration into 
reactive lymph nodes, inhibited both DC maturation and T 
cell priming. The effi   ciency of CD4  +   T  EM   cells in inducing 
DC maturation may rely on the anatomy of the lymph node, 
which places extravasating T  EM   cells in direct contact with 
DCs, and on the high numbers and motility of T  EM   cells, and 
hence, their ability to interact with multiple DCs in a serial 
fashion (  38  ). Although our results indicate that DC matura-
tion and licensing is selectively induced by T  EM   cells but not 
by naive or T  CM   cells, we cannot rule out the possibility that 
constitutive expression of CD40L on the latter may contribute 
to DC survival and function. Indeed, CD40L on mouse naive 
maturation and to license them for T cell priming (  37  ). Con-
stitutive CD40L expression was signifi  cantly higher in T  EM   
cells as compared with naive or T  CM   cells, and only T  EM   cells, 
but not naive or T  CM   cells, triggered DC maturation and pro-
moted T cell priming in vitro in an antigen-independent and 
CD40-dependent fashion. Importantly, this eff  ect was also 
observed in vivo. DCs in chronic reactive lymph nodes, ex-
posed to recirculating CD4  +   T  EM   cells, homogeneously ex-
pressed high levels of MHC and co-stimulatory molecules and 
were able to trigger naive T cell proliferation in response to 
antigens administered in the absence of adjuvants. The critical 
role of T  EM   cells was demonstrated by the fact that injection of 
    Figure 6.         EAE can be induced by presentation of MOG peptides in reactive lymph nodes and is inhibited by CD62P blockade.   Groups of mice 
(  n   = 16), either untreated (a and b) or that had received 30 d earlier an s.c. injection of CFA or two consecutive s.c. injections of LPS-matured DCs to in-
duce a chronic reactive lymph node (c and d), were challenged i.v. with 100   μ  g MOG  35-55   peptide in CFA (a) or in PBS (b  –  d). For each experimental group, 
half of the mice received once a week an i.v. injection of 100   μ  g CD62P antibodies (circles) or isotype matched control antibodies (squares) for the entire 
duration of the experiment. Mice were graded daily for clinical manifestation of EAE. Shown are mean clinical scores of eight mice per group. Error bars 
represent the SE for each point. (right) CD4 expression on lymphocytes isolated from the brain and spinal cords of mice 20 d after priming with MOG 
peptide. Numbers are the percentage of the gated population. Results are representative of two separate experiments.     JEM VOL. 205, October 27, 2008 
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CXCR3      /      mice were provided by C. Gerard (Harvard Medical School, 
Boston, MA). CD3e      /      mice (  53  ) were obtained from B. Malissen (Centre 
d  ’  Immunologie Marseille-Luminy, Marseille, France). All transgenic mice 
used in this study were on a Rag2      /      background. Mice were treated in ac-
cordance with the Swiss Federal Veterinary Offi   ce guidelines, and approval 
for animal experiments was obtained by the committee of the same offi   ce. 
  DCs and cell transfer.     BM-derived DCs were generated as previously de-
scribed (  54  ) by culturing BM precursors from femurs of mice in RPMI 1640 
medium supplemented with 10% (vol/vol) FCS, 1% (vol/vol) Glutamax, 1% 
(vol/vol) nonessential amino acids, 1% (vol/vol) pyruvate, 50 U/ml penicil-
lin, 50   μ  g/ml streptomycin (all from Invitrogen), and 50   μ  g/ml 2-mercapto-
ethanol (Merck) in the presence of recombinant GM-CSF (R  &  D Systems). 
DC maturation was induced by overnight incubation with 0.5   μ  g/ml LPS 
(Sigma-Aldrich). Whole spleen cells were labeled with 0.3 or 2.5   μ  M CFSE 
(Invitrogen) or with 10   μ  M 5- and 6-(4-chloromethyl)benzoyl-amino-
tetramethylrhodamine (Invitrogen). For in vivo blocking experiments, puri-
fi  ed anti-CD62L, anti-CD62P, anti-CD62E, or isotype control antibodies 
(all from BD Biosciences) were injected i.v (100   μ  g per mouse). These ex-
periments were performed either before or after transfer of fl  uorescently la-
beled cells and before or after injection of DCs, as indicated in the fi  gures. 
  Immunization.     The following proteins and peptides were used: whole 
OVA protein was obtained from Sigma-Aldrich and KLH was obtained from 
EMD; purifi  ed HA of infl  uenza A/IVR116 (H1N1) virus was a gift of 
G. Galli (Novartis, Siena, Italy); and OVA  323-339   (ISQAVHAAHAEINEAGR), 
HA  110-119   (SFERFEIFPK), and MOG  35-55   (MEVGWYRSPFSRVVH-
LYRNGK) peptides were synthesized by the Servei de Prote  ò  mica (Pompeu 
Fabra University, Barcelona, Spain). For immunization with adjuvant, 50   μ  g 
of whole protein was emulsifi  ed in CFA (DIFCO) and injected s.c. in the 
fl  ank. Where indicated in the fi  gures, immunization was performed i.v. with 
10   μ  g OVA or HA in PBS. 3  –  4 wk after priming, CD4  +   T cells were en-
riched from spleen and peripheral lymph nodes with CD4 magnetic beads 
(Miltenyi Biotec) and sorted using a FACSAria (BD Biosciences) according to 
the expression of CD44, CD62L, and CD127. Transgenic Thy1.1  +   DO11.10 
CD4  +   T cells were purifi  ed from spleen and lymph nodes and labeled with 
2.5   μ  M CFSE, and 10  6   cells were injected i.v. into syngeneic hosts. Adop-
tively transferred mice received one (DC 1  ×  ) or two consecutive (2 d apart; 
DC 2  ×  ) s.c. injections of 10  6   OVA-loaded, LPS-matured DCs. 3  –  4 wk after 
priming, DO11.10 CD4  +   T cells were enriched from spleen and lymph nodes 
by cell sorting according to the expression of CD44, CD62L, and CD127 
(T  CM  , CD44  high  CD62L  +  CD127  +  ; T  EM  , CD44  high  CD62L       CD127  +  ). Naive T 
cells (CD44  low  CD62L  +  CD127  +  ) were purifi   ed from spleens of Rag2      /      
DO11.10 mice. CD4  +   naive T, T  CM  , and T  EM   cells were adoptively trans-
ferred into syngeneic hosts or used in vitro, as indicated in the fi  gures. Reac-
tive lymph nodes were in some experiments induced by s.c. injection of LPS, 
CpG  1826   oligodeoxynucleotide (5    -CCATGACGTTCCTGACGTT-3    ; 
Microsynth), IFA (DIFCO), or CFA. Peritonitis was induced by an i.p. injec-
tion of a 3% solution (wt/vol) of thioglycolate (Sigma-Aldrich) in PBS. 
  In vitro experiments.     Naive antigen-specifi  c CD4  +   T cells were primed 
in vitro with immature or with LPS-matured DCs pulsed with the peptides 
indicated in the fi  gures (T cell/DC ratio = 10:1). CD4  +   naive T, T  CM  , or 
T  EM   cells specifi  c for a diff  erent antigen were added to these cultures. Poly-
clonal and OT-II CD4  +   T cells were primed in vivo, and 3 wk later T  EM   
CD4  +   T cells were sorted as before and expanded in vitro with 10   μ  g/ml 
each of anti-CD3 and anti-CD28 (both from BD Biosciences). On day 4, 
cultures were supplemented with 10 U/ml of human recombinant IL-2 (  55  ), 
and cells were collected 7  –  9 d later. To measure surface expression of 
CD40L, CD4  +   T cells were activated in vitro with soluble 10   μ  g/ml anti-
CD3 (BD Biosciences) and 10 ng/ml phorbol-12,13 dibutyrate (PDBu; 
Sigma-Aldrich). At the time points after stimulation indicated in the fi  gures, 
cold PBS containing 5% FCS was added to the cells. Immature BM-DCs 
were prepared and co-cultured in vitro with naive or in vivo  –  generated T  CM   
or T  EM   CD4  +   T cells. DCs were analyzed for expression of CD40, CD86, 
T cells has been shown to be suffi   cient to promote survival of 
autoreactive B cells (  19  ). 
  Microbial products have been shown to be required to 
break tolerance to tissue antigens, leading to autoimmunity 
(  39  ). In addition, LPS may activate autoreactive CD4  +   cells in 
a bystander fashion (  40  ). Based on our fi  ndings, we hypothe-
sized that the DC licensing eff  ect exerted by CD40L  +   CD4  +   
T  EM   cells traffi   cking into reactive lymph nodes may facilitate 
immune responses to poorly immunogenic antigens, such as 
tissue antigens, in the apparent absence of microbial products. 
This possibility was demonstrated by the fi   nding that EAE 
could be induced by injection of a MOG peptide at a site drain-
ing into the chronic reactive lymph node accessible to circulat-
ing antigen-nonspecific T  EM   cells. Although endogenous 
danger signals, such as ATP or uric acid (  41  ), may play a syner-
gistic role in the priming of autoreactive T cells, the fi  nding 
that the mere exclusion of T  EM   cells form the reactive lymph 
nodes by CD62P antibody treatment was suffi   cient to prevent 
immuno  pathology points to T  EM   cells as the primary inducing 
factor in eliciting this pathogenic response. Although it is pre-
mature to envisage a role for CD40L constitutively expressed 
on CD4  +   T  EM   cells in induction of autoimmune diseases, it is 
of note that increased levels of CD40L-expressing eff  ector and 
memory T cells have been observed in autoimmune-prone mice 
(  17  ) and in human memory T cells of patients with multiple 
sclerosis (  42  –  44  ), and targeting the CD40  –  CD40L interaction 
has been proposed as a treatment for autoimmune diseases or to 
induce allograft tolerance (  45, 46  ). In addition, activated CD4  +   
T cells have been shown to prime and expand endogenous auto-
reactive CD8  +   T cells in an antigen-dependent or -indepen-
dent fashion through the licensing of DCs via CD40L (  47, 48  ). 
We found that clinical symptoms and the extent of T cell infi  l-
tration were comparable in mice immunized with MOG in 
CFA or with soluble MOG draining into a reactive lymph 
node. It remains to be established whether these distinctive 
priming environments generate a comparable spectrum of po-
larized eff  ector T cells (  49  ). 
  In conclusion, our study provides evidence for a mecha-
nistic link between changes in cell traffi   c in lymph nodes 
and predisposition to mount eff  ector responses to otherwise 
nonimmunogenic antigens. We are currently testing the pos-
sibility that induction of chronic reactive lymph nodes at sites 
that drain tumor antigens may facilitate priming of eff  ector 
T cells against the tumor. 
  MATERIALS AND METHODS 
  Mice.     C57BL/6 (H-2  b  ) and BALB/c (H-2  d  ) mice were purchased from Har-
lan. Transgenic DO11.10-Thy1.2 (H-2  d  ) mice were purchased from Taconic. 
BALB/c-Thy1.1 mice, a gift of S.L. Swain (The Trudeau Institute, Saranac 
Lake, NY), were bred onto DO11.10-Thy1.2 mice in the animal facility of 
the Institute for Research in Biomedicine. Transgenic OT-II (H-2  b  ) (  50  ) and 
HA-TCR (H2  d  ) (  51  ) mice were obtained from J. Kirberg (Max-Plank-Insti-
tute of Immunobiology, Freiburg, Germany). The OT-II transgenic mice 
were also bred onto backgrounds of diff  erent CD45 alleles. CD62P/CD62E 
double-defi  cient mice (H-2  b  ) were a gift of R.O. Hynes (Massachusetts Insti-
tute of Technology, Boston, MA) through B. Engelhardt (Theodor Kocher 
Institute, Bern, Switzerland). CD40-defi  cient mice (H-2  b  ) (  52  ) were ob-
tained from K. Schwarz (Cytos Biotechnology AG, Zurich, Switzerland). 2572 DENDRITIC CELL LICENSING BY CD4  +   EFFECTOR MEMORY T CELLS   | Mart  í  n-Fontecha et al. 
medium, and layered onto a Lympholyte-M density gradient (Cedarlane). 
Tubes were centrifuged at room temperature for 20 min at 800   g  . Viable 
lymphocytes were removed from the interface. 
  Statistical analysis.     Data, presented as means   ±   SD, were analyzed with a 
paired Student  ’  s   t   test using the SPSS software (v16). P   <   0.05 was consid-
ered signifi  cant. 
  Online supplemental material.     Fig. S1 shows the sorting strategy for T 
naive, T  CM  , and T  EM   cells. Fig. S2 shows that adoptively transferred naive T 
and T  EM   cells localized in the same area in reactive lymph nodes. Fig. S3 
shows that T  EM   cell migration into the reactive lymph node is not dependent 
on the presence of specifi  c antigen, and that T  EM   cells do not represent a resi-
dent population in reactive lymph nodes. Fig. S4 shows that T cells may be 
required for induction of chronic reactive lymph nodes. Fig. S5 shows the 
absolute number of DO11.10 T  EM   cells in chronic reactive lymph nodes in 
the experiment in   Fig. 5  . 
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